Akeso, Inc. (9926.HK) (Akeso or the Company)  announced that the first patient has been dosed in a Phase II clinical study ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...

· Says ruling party wants the 2027 election to be about personalities not policies· Former VP dismisses Tinubu's economic policies · Alleges 767 factories shut, 335 in distressAfrican Democratic ...

SHANGHAI, Aug. 4, 2026 /PRNewswire/ -- AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), ...

South Korea's pharmaceutical and biotech industry is accelerating what it calls "AX" — AI transformation — embedding ...

Discussion explores how combining complementary payload technologies may unlock new therapeutic opportunities while ...

In the past month, Laurus Labs outperformed the market by surging 22 per cent, as compared to 2.1 per cent rise in the Nifty ...

FDA RMAT designation received for lasme-cel ; Full Phase 1 clinical data from the BALLI-01 trial presented at EHA 2026 ; Pivotal ...

Good day, everyone, and welcome to Pfizer's Second Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief ...

Q2 2026 earnings call highlights: revenue +11%, profitability, $717.5M cash, Zoci timeline and 2027 growth outlook—read now.